心臓インプラントの世界市場

心臓インプラントの世界市場は2030年までに578億米ドルに到達

2024年に375億米ドルと推定される心臓インプラントの世界市場は、分析期間2024-2030年にCAGR 7.5%で成長し、2030年には578億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである植込み型除細動器は、CAGR 9.4%を記録し、分析期間終了時には164億米ドルに達すると予測されます。ペースメーカー分野の成長率は、分析期間中CAGR 8.6%と推定されます。

米国市場は102億米ドル、中国はCAGR11.9％で成長予測

米国の心臓インプラント市場は、2024年に102億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに124億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは11.9%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ3.6%と7.3%と予測されています。欧州では、ドイツがCAGR 4.9%で成長すると予測されています。

世界の心臓インプラント市場- 主要動向と促進要因のまとめ

心臓インプラントが心血管疾患管理の中心になりつつある理由とは？

心臓インプラントは、広範な心血管疾患の治療および管理において、救命および生命強化のための医療機器として採用されるケースが増えています。不整脈、冠動脈疾患、心不全などの心臓関連疾患の世界の負担が増加の一途をたどる中、これらのインプラントは正常な心臓機能を回復させ、患者の生存率を向上させる上で極めて重要な役割を果たしています。心臓インプラントには、ペースメーカー、植込み型除細動器（ICD）、心臓再同期療法（CRT）機器、補助人工心臓（VAD）、心臓弁など、さまざまな機器が含まれます。これらはそれぞれ、不規則な心拍を調整したり、弱った心臓を機械的にサポートしたりと、特殊な機能を果たしています。世界中で高齢化が進み、座りっぱなしの生活や食生活の悪化が心血管疾患の急増につながり、効果的な治療法の必要性が高まっています。心臓インプラントは、治療上の利点だけでなく、遠隔モニタリング機能による診断能力も提供しており、医師は患者の心機能をリアルタイムで追跡し、タイムリーな臨床判断を下すことができます。また、低侵襲手術の需要は、外科的外傷が少なく回復が早い新世代のインプラントの採用を後押ししています。多くの末期心疾患患者にとって、インプラントは移植に代わる唯一の選択肢です。先進国、新興経済諸国ともに、早期診断に対する意識が高まり、ヘルスケア技術へのアクセスが向上していることから、心臓インプラントは現代の心臓血管治療戦略にとって不可欠な要素となっています。

技術革新は、現代の心臓インプラントのデザインと機能をどのように形成しているのでしょうか？

技術の進歩は心臓インプラントを急速に変化させ、より小さく、よりスマートに、そしてより効果的にしています。最も注目すべき開発のひとつは、デバイスの小型化であり、より低侵襲なインプラントを可能にし、患者の快適性を向上させています。これらの小型インプラントはまた、より長い電池寿命と強化された電力効率を備え、頻繁な交換の必要性を減らしています。ワイヤレス通信とBluetooth対応のテレメトリーが組み込まれたことで、リアルタイムの遠隔モニタリングが導入され、インプラントから医師のモニタリングシステムへの継続的なデータ送信が可能になりました。このコネクティビティは診断精度を高めるだけでなく、機器の故障や患者の状態が悪化した場合に積極的な介入を可能にします。AIアルゴリズムとデータ分析プラットフォームは現在、心臓リズムを分析し、合併症を予測し、治療を個別化するために統合されつつあります。リードレスペースメーカーの登場は、従来のリードに伴う合併症に対処し、感染や機械的故障のリスクを低減しています。生体適合性のある材料と高度なコーティング技術は、炎症反応を抑え、長期的な機能性を向上させることにより、インプラントの安全性プロファイルをさらに改善しました。心不全患者にとって、新世代の補助人工心臓は小型化され、静音化されたことで、より日常生活に適したものとなり、心理的苦痛も軽減されました。さらに、生体吸収性スキャフォールドや組織工学的心臓弁の画期的な進歩により、特に小児や従来の器具を卒業した若年層の患者において、時間の経過とともに自然に体になじむインプラントへの道が開かれつつあります。また、ロボット支援による移植手技の革新により、手技の精度が向上し、手術時間が短縮されつつあります。技術が進化し続けるにつれ、心臓インプラントは、治療だけでなく、患者固有のニーズに適応し、学習し、予測するように設計されるようになってきています。

心臓インプラントの世界の需要は、どのような地域や人口統計学的パターンが牽引しているのでしょうか？

心臓インプラントの世界の需要は、地域ごとのヘルスケアのダイナミクス、人口動態の変化、疾患の流行パターンの組み合わせによって影響を受けています。北米、特に米国とカナダでは、心血管疾患の割合が高く、高度なヘルスケアインフラと有利な償還政策により、心臓インプラントの主要市場となっています。欧州は、ドイツ、フランス、英国などが早期診断やインターベンショナル・カーディオロジーに多額の投資を行っており、植込み型機器の普及が進んでいます。アジア太平洋では、急速な都市化、ライフスタイルの変化、高血圧、糖尿病、肥満の増加が心臓病患者の急増に寄与しています。中国、インド、日本などの国々では、都市部でも農村部でも心臓治療施設を拡大する政府の取り組みとともに、医療費の増加が見られます。治療に対する認識とアクセスが向上するにつれて、これらの国々は心臓インプラントメーカーにとって将来性の高い市場として浮上しています。ラテンアメリカと中東の一部では、民間ヘルスケア部門の拡大と医療ツーリズムが需要の増加を促進しているが、一部の地域では高額な機器費用と限られた償還が障壁となっています。高齢者は不整脈、心不全、弁の変性に罹患しやすいからです。しかし、先天性心疾患や遺伝的疾患を持つ若年患者も、長期使用と合併症発生率の低下を目的に設計された新しいインプラント技術の恩恵を受けています。心血管系スクリーニング・プログラムや専門医療センターの拡大が診断率をさらに高めており、これはすべての年齢層と地域でインプラント埋込み量の増加に直結しています。

世界の心臓インプラント市場の成長を促進する主な要因は？

心臓インプラント市場の成長は、疫学的動向、技術革新、ヘルスケアインフラ、患者の期待の変化を中心としたいくつかの強力な力によって牽引されています。まず第一に、人口の高齢化と肥満、喫煙、糖尿病などの生活習慣に関連した危険因子に後押しされた心血管疾患の世界の有病率の上昇が、インプラントのようなインターベンション・ソリューションに対する常に高いニーズを生み出しています。同時に、リードレスペースメーカー、スマートセンサー、MRI対応機器など、インプラント技術の改良が進み、心臓機器の臨床範囲と安全性プロファイルが拡大しています。低侵襲手術の推進も需要に影響を及ぼしています。新しいインプラントの設計は、回復の早さと入院期間の短縮を可能にし、これは価値ベースのヘルスケアシステムにおいてますます重要な指標となっています。遠隔医療や遠隔モニタリング技術の拡大により、インプラント治療後のケアやコンプライアンスが向上し、これらの治療法の長期的な成功率が高まっています。早期治療の選択肢に関する患者・臨床医双方の意識の高まりは、早期診断と早期インプラント介入をもたらし、患者の転帰を改善しています。新興市場では、ヘルスケア投資の拡大、保険へのアクセスの改善、心臓専門センターの設立により、より多くの患者がインプラントを含む処置を受けられるようになっています。さらに、心血管系死亡率の減少に焦点を当てた政府および非政府の医療イニシアティブが、広範なスクリーニングとデバイスベースの治療への資金提供を支援しています。最後に、医療機器企業とヘルスケアプロバイダーとの戦略的パートナーシップにより、流通、トレーニング、市販後のサポートが改善され、以前は十分に浸透していなかった市場でのインプラントの導入が加速しています。これらの要因が相まって、世界の心臓インプラント市場の持続的な拡大が保証され、現在および将来の心血管治療における重要な役割が強化されています。

セグメント

製品（植え込み型除細動器、ペースメーカー、冠動脈ステント、植え込み型心拍モニター、植え込み型血行動態モニター、その他製品）、用途（不整脈用途、急性心筋梗塞用途、心筋虚血用途、その他用途）、エンドユーザー（病院エンドユーザー、循環器センターエンドユーザー、その他エンドユーザー）

調査対象企業の例

• Abiomed, Inc.
• Abbott Laboratories
• B. Braun Melsungen AG
• Berlin Heart GmbH
• Biotronik SE & Co. KG
• Boston Scientific Corporation
• Cardiac Science Corporation
• Cook Medical Incorporated
• CryoLife, Inc.
• Edwards Lifesciences Corporation
• Jarvik Heart, Inc.
• Johnson & Johnson（Ethicon/BIOL）
• Lepu Medical Technology Co., Ltd.
• LivaNova plc
• Medico S.p.A.
• Medtronic plc
• Meril Life Sciences Pvt. Ltd.
• MicroPort Scientific Corporation
• Zimmer Biomet Holdings, Inc.

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、一般的なLLMや業界別SLMのクエリに従う代わりに、ビデオ記録、ブログ、検索エンジン調査、大量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

第4章 競合

Global Cardiac Implants Market to Reach US$57.8 Billion by 2030

The global market for Cardiac Implants estimated at US$37.5 Billion in the year 2024, is expected to reach US$57.8 Billion by 2030, growing at a CAGR of 7.5% over the analysis period 2024-2030. Implantable Cardioverter-defibrillators, one of the segments analyzed in the report, is expected to record a 9.4% CAGR and reach US$16.4 Billion by the end of the analysis period. Growth in the Pacemakers segment is estimated at 8.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$10.2 Billion While China is Forecast to Grow at 11.9% CAGR

The Cardiac Implants market in the U.S. is estimated at US$10.2 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$12.4 Billion by the year 2030 trailing a CAGR of 11.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.6% and 7.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.9% CAGR.

Global Cardiac Implants Market - Key Trends & Drivers Summarized

Why Are Cardiac Implants Becoming Central to the Management of Cardiovascular Disorders?

Cardiac implants are increasingly being adopted as life-saving and life-enhancing medical devices in the treatment and management of a wide spectrum of cardiovascular diseases. As the global burden of heart-related conditions such as arrhythmias, coronary artery disease, and heart failure continues to rise, these implants are playing a pivotal role in restoring normal cardiac function and improving patient survival rates. Cardiac implants encompass a diverse range of devices including pacemakers, implantable cardioverter defibrillators (ICDs), cardiac resynchronization therapy (CRT) devices, ventricular assist devices (VADs), and heart valves. Each of these serves a specialized function, from regulating irregular heartbeats to providing mechanical support for weakened hearts. The growing prevalence of aging populations across the world, coupled with increasingly sedentary lifestyles and poor dietary habits, has contributed to a surge in cardiovascular ailments, further elevating the need for effective interventions. Cardiac implants offer not only therapeutic benefits but also diagnostic capabilities through remote monitoring features, allowing physicians to track a patient’s heart function in real time and make timely clinical decisions. The demand for minimally invasive procedures is also bolstering the adoption of newer-generation implants that require less surgical trauma and offer faster recovery. For many patients with end-stage heart disease, implants represent the only viable alternative to transplantation. The growing awareness of early diagnosis and the improved accessibility of healthcare technologies in both developed and emerging economies continue to make cardiac implants an integral component of modern cardiovascular care strategies.

How Are Technological Innovations Shaping the Design and Functionality of Modern Cardiac Implants?

Technological advancements are rapidly transforming the landscape of cardiac implants, making them smaller, smarter, and significantly more effective. One of the most notable developments is the miniaturization of devices, allowing for less invasive implantation and improved patient comfort. These smaller implants also come with longer battery lives and enhanced power efficiency, reducing the need for frequent replacements. The incorporation of wireless communication and Bluetooth-enabled telemetry has introduced real-time remote monitoring, enabling continuous data transmission from the implant to the physician’s monitoring system. This connectivity is not only enhancing diagnostic precision but also allowing for proactive intervention in cases of device malfunction or patient deterioration. AI algorithms and data analytics platforms are now being integrated to analyze heart rhythms, anticipate complications, and personalize treatment. The emergence of leadless pacemakers has addressed complications associated with traditional leads, offering reduced risk of infection and mechanical failure. Biocompatible materials and advanced coating technologies have further improved the safety profile of implants by reducing inflammatory responses and improving long-term functionality. For patients with heart failure, new-generation VADs are now smaller and quieter, making them more suitable for daily life and reducing psychological distress. Additionally, breakthroughs in bioresorbable scaffolds and tissue-engineered heart valves are paving the way for implants that can be naturally integrated into the body over time, particularly in pediatric or younger patients who outgrow traditional devices. Innovations in robotic-assisted implantation techniques are also improving procedural accuracy and reducing operation times. As technology continues to evolve, cardiac implants are increasingly being designed not only to treat but also to adapt, learn, and predict patient-specific needs.

What Regional and Demographic Patterns Are Driving Global Demand for Cardiac Implants?

The global demand for cardiac implants is being influenced by a combination of regional healthcare dynamics, demographic shifts, and disease prevalence patterns. In North America, particularly in the United States and Canada, high rates of cardiovascular disease combined with advanced healthcare infrastructure and favorable reimbursement policies have made the region a leading market for cardiac implants. Europe follows closely, with countries such as Germany, France, and the UK investing heavily in early diagnosis and interventional cardiology, thereby maintaining robust adoption of implantable devices. In Asia-Pacific, rapid urbanization, lifestyle changes, and increasing incidence of hypertension, diabetes, and obesity are contributing to a sharp rise in heart disease cases. Countries like China, India, and Japan are witnessing growing healthcare expenditures, along with government initiatives to expand cardiac care facilities in both urban and rural areas. As awareness and access to treatment improve, these countries are emerging as high-potential markets for cardiac implant manufacturers. In Latin America and parts of the Middle East, expanding private healthcare sectors and medical tourism are facilitating increased demand, although high device costs and limited reimbursement remain barriers in certain areas. Demographically, the aging global population is a key demand driver, as older adults are significantly more susceptible to arrhythmias, heart failure, and valve degeneration. However, younger patients with congenital heart defects or genetic conditions are also benefiting from new implant technologies designed for long-term use and lower complication rates. The widening reach of cardiovascular screening programs and specialist care centers is further increasing the diagnosis rates, which directly correlates with higher implant volumes across all age groups and regions.

What Are the Key Drivers Propelling Growth in the Global Cardiac Implants Market?

The growth in the cardiac implants market is driven by several powerful forces centered around epidemiological trends, technological innovation, healthcare infrastructure, and shifting patient expectations. First and foremost, the rising global prevalence of cardiovascular diseases, fueled by aging populations and lifestyle-related risk factors such as obesity, smoking, and diabetes, is creating a consistently high need for interventional solutions like implants. Simultaneously, ongoing improvements in implant technology, including leadless pacemakers, smart sensors, and MRI-compatible devices, are expanding the clinical scope and safety profile of cardiac devices. The push for minimally invasive procedures is also influencing demand, as new implant designs allow for faster recovery and reduced hospital stays, which are increasingly important metrics in value-based healthcare systems. The expansion of telemedicine and remote monitoring technologies is facilitating better post-implant care and compliance, increasing the long-term success rates of these interventions. Increased awareness among both patients and clinicians regarding early treatment options is resulting in earlier diagnosis and implant intervention, improving patient outcomes. In emerging markets, growing healthcare investments, improved access to insurance, and the establishment of cardiac specialty centers are enabling more patients to undergo procedures involving implants. Moreover, government and non-government health initiatives focusing on reducing cardiovascular mortality are supporting widespread screening and funding for device-based treatment. Finally, strategic partnerships between medical device companies and healthcare providers are improving distribution, training, and post-market support, accelerating the adoption of implants in previously underpenetrated markets. Together, these factors are ensuring sustained expansion of the global cardiac implants market, reinforcing its critical role in contemporary and future cardiovascular care.

SCOPE OF STUDY:

The report analyzes the Cardiac Implants market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors, Other Products); Application (Arrhythmias Application, Acute Myocardial Infarction Application, Myocardial Ischemia Application, Other Applications); End-User (Hospitals End-Users, Cardiology Centers End-Users, Other End-Users)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 43 Featured) -

• Abiomed, Inc.
• Abbott Laboratories
• B. Braun Melsungen AG
• Berlin Heart GmbH
• Biotronik SE & Co. KG
• Boston Scientific Corporation
• Cardiac Science Corporation
• Cook Medical Incorporated
• CryoLife, Inc.
• Edwards Lifesciences Corporation
• Jarvik Heart, Inc.
• Johnson & Johnson (Ethicon/BIOL)
• Lepu Medical Technology Co., Ltd.
• LivaNova plc
• Medico S.p.A.
• Medtronic plc
• Meril Life Sciences Pvt. Ltd.
• MicroPort Scientific Corporation
• Zimmer Biomet Holdings, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Tariff Impact on Global Supply Chain Patterns
  • Cardiac Implants - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Global Burden of Cardiovascular Diseases Throws the Spotlight on Cardiac Implants as Life-Saving Interventions
  • Increasing Aging Population Spurs Demand for Long-Term Implantable Solutions for Heart Rhythm and Structural Disorders
  • Here's the Story: How Advancements in Minimally Invasive Procedures Are Expanding Access to Cardiac Implant Therapies
  • Technological Innovations in Pacemakers, Defibrillators, and Heart Valves Strengthen Business Case for Next-Gen Devices
  • Growth in Transcatheter and Leadless Implant Technologies Fuels Market Expansion Across Risk Categories
  • Here's How Remote Monitoring and Smart Implants Are Reshaping Post-Operative Cardiac Care
  • Rising Adoption of Left Ventricular Assist Devices (LVADs) and Artificial Hearts Drives Demand in Advanced Heart Failure Management
  • Global Expansion of Electrophysiology Labs and Structural Heart Programs Supports Implant Procedure Volumes
  • Growing Awareness and Screening Initiatives Drive Early Diagnosis and Prophylactic Implantation
  • Rising Burden of Lifestyle-Related Risk Factors Fuels Preventive Use of Cardiac Rhythm Management Devices
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Cardiac Implants Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Cardiac Implants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Cardiac Implants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 4: World 16-Year Perspective for Cardiac Implants by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Implantable Cardioverter-defibrillators by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Implantable Cardioverter-defibrillators by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 7: World 16-Year Perspective for Implantable Cardioverter-defibrillators by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Pacemakers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Pacemakers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 10: World 16-Year Perspective for Pacemakers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Coronary Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Coronary Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 13: World 16-Year Perspective for Coronary Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Implantable Heart Rhythm Monitors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Implantable Heart Rhythm Monitors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 16: World 16-Year Perspective for Implantable Heart Rhythm Monitors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Implantable Hemodynamic Monitors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Implantable Hemodynamic Monitors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 19: World 16-Year Perspective for Implantable Hemodynamic Monitors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 22: World 16-Year Perspective for Other Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 25: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Arrhythmias Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Arrhythmias Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 28: World 16-Year Perspective for Arrhythmias Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Acute Myocardial Infarction Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Acute Myocardial Infarction Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 31: World 16-Year Perspective for Acute Myocardial Infarction Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Myocardial Ischemia Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Myocardial Ischemia Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 34: World 16-Year Perspective for Myocardial Ischemia Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Hospitals End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Hospitals End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 37: World 16-Year Perspective for Hospitals End-Users by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for Cardiology Centers End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 39: World Historic Review for Cardiology Centers End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 40: World 16-Year Perspective for Cardiology Centers End-Users by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 41: World Recent Past, Current & Future Analysis for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 42: World Historic Review for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 43: World 16-Year Perspective for Other End-Users by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Cardiac Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 44: USA Recent Past, Current & Future Analysis for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 45: USA Historic Review for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 46: USA 16-Year Perspective for Cardiac Implants by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products for the Years 2014, 2025 & 2030
  • TABLE 47: USA Recent Past, Current & Future Analysis for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 48: USA Historic Review for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 49: USA 16-Year Perspective for Cardiac Implants by Application - Percentage Breakdown of Value Sales for Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application for the Years 2014, 2025 & 2030
  • TABLE 50: USA Recent Past, Current & Future Analysis for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 51: USA Historic Review for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 52: USA 16-Year Perspective for Cardiac Implants by End-user - Percentage Breakdown of Value Sales for Hospitals End-Users, Cardiology Centers End-Users and Other End-Users for the Years 2014, 2025 & 2030
• CANADA
  • TABLE 53: Canada Recent Past, Current & Future Analysis for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Canada Historic Review for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 55: Canada 16-Year Perspective for Cardiac Implants by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products for the Years 2014, 2025 & 2030
  • TABLE 56: Canada Recent Past, Current & Future Analysis for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Canada Historic Review for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 58: Canada 16-Year Perspective for Cardiac Implants by Application - Percentage Breakdown of Value Sales for Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application for the Years 2014, 2025 & 2030
  • TABLE 59: Canada Recent Past, Current & Future Analysis for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Canada Historic Review for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 61: Canada 16-Year Perspective for Cardiac Implants by End-user - Percentage Breakdown of Value Sales for Hospitals End-Users, Cardiology Centers End-Users and Other End-Users for the Years 2014, 2025 & 2030
• JAPAN
  • Cardiac Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 62: Japan Recent Past, Current & Future Analysis for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Japan Historic Review for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 64: Japan 16-Year Perspective for Cardiac Implants by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products for the Years 2014, 2025 & 2030
  • TABLE 65: Japan Recent Past, Current & Future Analysis for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Japan Historic Review for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 67: Japan 16-Year Perspective for Cardiac Implants by Application - Percentage Breakdown of Value Sales for Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application for the Years 2014, 2025 & 2030
  • TABLE 68: Japan Recent Past, Current & Future Analysis for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Japan Historic Review for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 70: Japan 16-Year Perspective for Cardiac Implants by End-user - Percentage Breakdown of Value Sales for Hospitals End-Users, Cardiology Centers End-Users and Other End-Users for the Years 2014, 2025 & 2030
• CHINA
  • Cardiac Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 71: China Recent Past, Current & Future Analysis for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: China Historic Review for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 73: China 16-Year Perspective for Cardiac Implants by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products for the Years 2014, 2025 & 2030
  • TABLE 74: China Recent Past, Current & Future Analysis for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: China Historic Review for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 76: China 16-Year Perspective for Cardiac Implants by Application - Percentage Breakdown of Value Sales for Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application for the Years 2014, 2025 & 2030
  • TABLE 77: China Recent Past, Current & Future Analysis for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 78: China Historic Review for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 79: China 16-Year Perspective for Cardiac Implants by End-user - Percentage Breakdown of Value Sales for Hospitals End-Users, Cardiology Centers End-Users and Other End-Users for the Years 2014, 2025 & 2030
• EUROPE
  • Cardiac Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 80: Europe Recent Past, Current & Future Analysis for Cardiac Implants by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 81: Europe Historic Review for Cardiac Implants by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 82: Europe 16-Year Perspective for Cardiac Implants by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
  • TABLE 83: Europe Recent Past, Current & Future Analysis for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: Europe Historic Review for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 85: Europe 16-Year Perspective for Cardiac Implants by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products for the Years 2014, 2025 & 2030
  • TABLE 86: Europe Recent Past, Current & Future Analysis for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Europe Historic Review for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 88: Europe 16-Year Perspective for Cardiac Implants by Application - Percentage Breakdown of Value Sales for Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application for the Years 2014, 2025 & 2030
  • TABLE 89: Europe Recent Past, Current & Future Analysis for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Europe Historic Review for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 91: Europe 16-Year Perspective for Cardiac Implants by End-user - Percentage Breakdown of Value Sales for Hospitals End-Users, Cardiology Centers End-Users and Other End-Users for the Years 2014, 2025 & 2030
• FRANCE
  • Cardiac Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 92: France Recent Past, Current & Future Analysis for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: France Historic Review for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 94: France 16-Year Perspective for Cardiac Implants by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products for the Years 2014, 2025 & 2030
  • TABLE 95: France Recent Past, Current & Future Analysis for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: France Historic Review for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 97: France 16-Year Perspective for Cardiac Implants by Application - Percentage Breakdown of Value Sales for Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application for the Years 2014, 2025 & 2030
  • TABLE 98: France Recent Past, Current & Future Analysis for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: France Historic Review for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 100: France 16-Year Perspective for Cardiac Implants by End-user - Percentage Breakdown of Value Sales for Hospitals End-Users, Cardiology Centers End-Users and Other End-Users for the Years 2014, 2025 & 2030
• GERMANY
  • Cardiac Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 101: Germany Recent Past, Current & Future Analysis for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Germany Historic Review for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 103: Germany 16-Year Perspective for Cardiac Implants by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products for the Years 2014, 2025 & 2030
  • TABLE 104: Germany Recent Past, Current & Future Analysis for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Germany Historic Review for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 106: Germany 16-Year Perspective for Cardiac Implants by Application - Percentage Breakdown of Value Sales for Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application for the Years 2014, 2025 & 2030
  • TABLE 107: Germany Recent Past, Current & Future Analysis for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Germany Historic Review for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 109: Germany 16-Year Perspective for Cardiac Implants by End-user - Percentage Breakdown of Value Sales for Hospitals End-Users, Cardiology Centers End-Users and Other End-Users for the Years 2014, 2025 & 2030
• ITALY
  • TABLE 110: Italy Recent Past, Current & Future Analysis for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Italy Historic Review for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 112: Italy 16-Year Perspective for Cardiac Implants by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products for the Years 2014, 2025 & 2030
  • TABLE 113: Italy Recent Past, Current & Future Analysis for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Italy Historic Review for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 115: Italy 16-Year Perspective for Cardiac Implants by Application - Percentage Breakdown of Value Sales for Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application for the Years 2014, 2025 & 2030
  • TABLE 116: Italy Recent Past, Current & Future Analysis for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Italy Historic Review for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 118: Italy 16-Year Perspective for Cardiac Implants by End-user - Percentage Breakdown of Value Sales for Hospitals End-Users, Cardiology Centers End-Users and Other End-Users for the Years 2014, 2025 & 2030
• UNITED KINGDOM
  • Cardiac Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 119: UK Recent Past, Current & Future Analysis for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: UK Historic Review for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 121: UK 16-Year Perspective for Cardiac Implants by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products for the Years 2014, 2025 & 2030
  • TABLE 122: UK Recent Past, Current & Future Analysis for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: UK Historic Review for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 124: UK 16-Year Perspective for Cardiac Implants by Application - Percentage Breakdown of Value Sales for Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application for the Years 2014, 2025 & 2030
  • TABLE 125: UK Recent Past, Current & Future Analysis for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: UK Historic Review for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 127: UK 16-Year Perspective for Cardiac Implants by End-user - Percentage Breakdown of Value Sales for Hospitals End-Users, Cardiology Centers End-Users and Other End-Users for the Years 2014, 2025 & 2030
• SPAIN
  • TABLE 128: Spain Recent Past, Current & Future Analysis for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Spain Historic Review for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 130: Spain 16-Year Perspective for Cardiac Implants by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products for the Years 2014, 2025 & 2030
  • TABLE 131: Spain Recent Past, Current & Future Analysis for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Spain Historic Review for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 133: Spain 16-Year Perspective for Cardiac Implants by Application - Percentage Breakdown of Value Sales for Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application for the Years 2014, 2025 & 2030
  • TABLE 134: Spain Recent Past, Current & Future Analysis for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Spain Historic Review for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 136: Spain 16-Year Perspective for Cardiac Implants by End-user - Percentage Breakdown of Value Sales for Hospitals End-Users, Cardiology Centers End-Users and Other End-Users for the Years 2014, 2025 & 2030
• RUSSIA
  • TABLE 137: Russia Recent Past, Current & Future Analysis for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Russia Historic Review for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 139: Russia 16-Year Perspective for Cardiac Implants by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products for the Years 2014, 2025 & 2030
  • TABLE 140: Russia Recent Past, Current & Future Analysis for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Russia Historic Review for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 142: Russia 16-Year Perspective for Cardiac Implants by Application - Percentage Breakdown of Value Sales for Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application for the Years 2014, 2025 & 2030
  • TABLE 143: Russia Recent Past, Current & Future Analysis for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Russia Historic Review for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 145: Russia 16-Year Perspective for Cardiac Implants by End-user - Percentage Breakdown of Value Sales for Hospitals End-Users, Cardiology Centers End-Users and Other End-Users for the Years 2014, 2025 & 2030
• REST OF EUROPE
  • TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Rest of Europe Historic Review for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 148: Rest of Europe 16-Year Perspective for Cardiac Implants by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products for the Years 2014, 2025 & 2030
  • TABLE 149: Rest of Europe Recent Past, Current & Future Analysis for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Rest of Europe Historic Review for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 151: Rest of Europe 16-Year Perspective for Cardiac Implants by Application - Percentage Breakdown of Value Sales for Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application for the Years 2014, 2025 & 2030
  • TABLE 152: Rest of Europe Recent Past, Current & Future Analysis for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Rest of Europe Historic Review for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 154: Rest of Europe 16-Year Perspective for Cardiac Implants by End-user - Percentage Breakdown of Value Sales for Hospitals End-Users, Cardiology Centers End-Users and Other End-Users for the Years 2014, 2025 & 2030
• ASIA-PACIFIC
  • Cardiac Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Cardiac Implants by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 156: Asia-Pacific Historic Review for Cardiac Implants by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 157: Asia-Pacific 16-Year Perspective for Cardiac Implants by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
  • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Asia-Pacific Historic Review for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 160: Asia-Pacific 16-Year Perspective for Cardiac Implants by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products for the Years 2014, 2025 & 2030
  • TABLE 161: Asia-Pacific Recent Past, Current & Future Analysis for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Asia-Pacific Historic Review for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 163: Asia-Pacific 16-Year Perspective for Cardiac Implants by Application - Percentage Breakdown of Value Sales for Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application for the Years 2014, 2025 & 2030
  • TABLE 164: Asia-Pacific Recent Past, Current & Future Analysis for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Asia-Pacific Historic Review for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 166: Asia-Pacific 16-Year Perspective for Cardiac Implants by End-user - Percentage Breakdown of Value Sales for Hospitals End-Users, Cardiology Centers End-Users and Other End-Users for the Years 2014, 2025 & 2030
• AUSTRALIA
  • Cardiac Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 167: Australia Recent Past, Current & Future Analysis for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Australia Historic Review for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 169: Australia 16-Year Perspective for Cardiac Implants by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products for the Years 2014, 2025 & 2030
  • TABLE 170: Australia Recent Past, Current & Future Analysis for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Australia Historic Review for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 172: Australia 16-Year Perspective for Cardiac Implants by Application - Percentage Breakdown of Value Sales for Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application for the Years 2014, 2025 & 2030
  • TABLE 173: Australia Recent Past, Current & Future Analysis for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: Australia Historic Review for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 175: Australia 16-Year Perspective for Cardiac Implants by End-user - Percentage Breakdown of Value Sales for Hospitals End-Users, Cardiology Centers End-Users and Other End-Users for the Years 2014, 2025 & 2030
• INDIA
  • Cardiac Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 176: India Recent Past, Current & Future Analysis for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: India Historic Review for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 178: India 16-Year Perspective for Cardiac Implants by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products for the Years 2014, 2025 & 2030
  • TABLE 179: India Recent Past, Current & Future Analysis for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: India Historic Review for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 181: India 16-Year Perspective for Cardiac Implants by Application - Percentage Breakdown of Value Sales for Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application for the Years 2014, 2025 & 2030
  • TABLE 182: India Recent Past, Current & Future Analysis for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: India Historic Review for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 184: India 16-Year Perspective for Cardiac Implants by End-user - Percentage Breakdown of Value Sales for Hospitals End-Users, Cardiology Centers End-Users and Other End-Users for the Years 2014, 2025 & 2030
• SOUTH KOREA
  • TABLE 185: South Korea Recent Past, Current & Future Analysis for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: South Korea Historic Review for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 187: South Korea 16-Year Perspective for Cardiac Implants by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products for the Years 2014, 2025 & 2030
  • TABLE 188: South Korea Recent Past, Current & Future Analysis for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: South Korea Historic Review for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 190: South Korea 16-Year Perspective for Cardiac Implants by Application - Percentage Breakdown of Value Sales for Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application for the Years 2014, 2025 & 2030
  • TABLE 191: South Korea Recent Past, Current & Future Analysis for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 192: South Korea Historic Review for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 193: South Korea 16-Year Perspective for Cardiac Implants by End-user - Percentage Breakdown of Value Sales for Hospitals End-Users, Cardiology Centers End-Users and Other End-Users for the Years 2014, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Rest of Asia-Pacific Historic Review for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 196: Rest of Asia-Pacific 16-Year Perspective for Cardiac Implants by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products for the Years 2014, 2025 & 2030
  • TABLE 197: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Rest of Asia-Pacific Historic Review for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 199: Rest of Asia-Pacific 16-Year Perspective for Cardiac Implants by Application - Percentage Breakdown of Value Sales for Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application for the Years 2014, 2025 & 2030
  • TABLE 200: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Rest of Asia-Pacific Historic Review for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 202: Rest of Asia-Pacific 16-Year Perspective for Cardiac Implants by End-user - Percentage Breakdown of Value Sales for Hospitals End-Users, Cardiology Centers End-Users and Other End-Users for the Years 2014, 2025 & 2030
• LATIN AMERICA
  • Cardiac Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 203: Latin America Recent Past, Current & Future Analysis for Cardiac Implants by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 204: Latin America Historic Review for Cardiac Implants by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 205: Latin America 16-Year Perspective for Cardiac Implants by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
  • TABLE 206: Latin America Recent Past, Current & Future Analysis for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Latin America Historic Review for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 208: Latin America 16-Year Perspective for Cardiac Implants by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products for the Years 2014, 2025 & 2030
  • TABLE 209: Latin America Recent Past, Current & Future Analysis for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Latin America Historic Review for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 211: Latin America 16-Year Perspective for Cardiac Implants by Application - Percentage Breakdown of Value Sales for Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application for the Years 2014, 2025 & 2030
  • TABLE 212: Latin America Recent Past, Current & Future Analysis for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Latin America Historic Review for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 214: Latin America 16-Year Perspective for Cardiac Implants by End-user - Percentage Breakdown of Value Sales for Hospitals End-Users, Cardiology Centers End-Users and Other End-Users for the Years 2014, 2025 & 2030
• ARGENTINA
  • TABLE 215: Argentina Recent Past, Current & Future Analysis for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Argentina Historic Review for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 217: Argentina 16-Year Perspective for Cardiac Implants by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products for the Years 2014, 2025 & 2030
  • TABLE 218: Argentina Recent Past, Current & Future Analysis for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Argentina Historic Review for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 220: Argentina 16-Year Perspective for Cardiac Implants by Application - Percentage Breakdown of Value Sales for Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application for the Years 2014, 2025 & 2030
  • TABLE 221: Argentina Recent Past, Current & Future Analysis for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Argentina Historic Review for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 223: Argentina 16-Year Perspective for Cardiac Implants by End-user - Percentage Breakdown of Value Sales for Hospitals End-Users, Cardiology Centers End-Users and Other End-Users for the Years 2014, 2025 & 2030
• BRAZIL
  • TABLE 224: Brazil Recent Past, Current & Future Analysis for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Brazil Historic Review for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 226: Brazil 16-Year Perspective for Cardiac Implants by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products for the Years 2014, 2025 & 2030
  • TABLE 227: Brazil Recent Past, Current & Future Analysis for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Brazil Historic Review for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 229: Brazil 16-Year Perspective for Cardiac Implants by Application - Percentage Breakdown of Value Sales for Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application for the Years 2014, 2025 & 2030
  • TABLE 230: Brazil Recent Past, Current & Future Analysis for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Brazil Historic Review for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 232: Brazil 16-Year Perspective for Cardiac Implants by End-user - Percentage Breakdown of Value Sales for Hospitals End-Users, Cardiology Centers End-Users and Other End-Users for the Years 2014, 2025 & 2030
• MEXICO
  • TABLE 233: Mexico Recent Past, Current & Future Analysis for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Mexico Historic Review for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 235: Mexico 16-Year Perspective for Cardiac Implants by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products for the Years 2014, 2025 & 2030
  • TABLE 236: Mexico Recent Past, Current & Future Analysis for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Mexico Historic Review for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 238: Mexico 16-Year Perspective for Cardiac Implants by Application - Percentage Breakdown of Value Sales for Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application for the Years 2014, 2025 & 2030
  • TABLE 239: Mexico Recent Past, Current & Future Analysis for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Mexico Historic Review for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 241: Mexico 16-Year Perspective for Cardiac Implants by End-user - Percentage Breakdown of Value Sales for Hospitals End-Users, Cardiology Centers End-Users and Other End-Users for the Years 2014, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Rest of Latin America Historic Review for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 244: Rest of Latin America 16-Year Perspective for Cardiac Implants by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products for the Years 2014, 2025 & 2030
  • TABLE 245: Rest of Latin America Recent Past, Current & Future Analysis for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Rest of Latin America Historic Review for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 247: Rest of Latin America 16-Year Perspective for Cardiac Implants by Application - Percentage Breakdown of Value Sales for Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application for the Years 2014, 2025 & 2030
  • TABLE 248: Rest of Latin America Recent Past, Current & Future Analysis for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Rest of Latin America Historic Review for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 250: Rest of Latin America 16-Year Perspective for Cardiac Implants by End-user - Percentage Breakdown of Value Sales for Hospitals End-Users, Cardiology Centers End-Users and Other End-Users for the Years 2014, 2025 & 2030
• MIDDLE EAST
  • Cardiac Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 251: Middle East Recent Past, Current & Future Analysis for Cardiac Implants by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 252: Middle East Historic Review for Cardiac Implants by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 253: Middle East 16-Year Perspective for Cardiac Implants by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
  • TABLE 254: Middle East Recent Past, Current & Future Analysis for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Middle East Historic Review for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 256: Middle East 16-Year Perspective for Cardiac Implants by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products for the Years 2014, 2025 & 2030
  • TABLE 257: Middle East Recent Past, Current & Future Analysis for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Middle East Historic Review for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 259: Middle East 16-Year Perspective for Cardiac Implants by Application - Percentage Breakdown of Value Sales for Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application for the Years 2014, 2025 & 2030
  • TABLE 260: Middle East Recent Past, Current & Future Analysis for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Middle East Historic Review for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 262: Middle East 16-Year Perspective for Cardiac Implants by End-user - Percentage Breakdown of Value Sales for Hospitals End-Users, Cardiology Centers End-Users and Other End-Users for the Years 2014, 2025 & 2030
• IRAN
  • TABLE 263: Iran Recent Past, Current & Future Analysis for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Iran Historic Review for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 265: Iran 16-Year Perspective for Cardiac Implants by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products for the Years 2014, 2025 & 2030
  • TABLE 266: Iran Recent Past, Current & Future Analysis for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Iran Historic Review for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 268: Iran 16-Year Perspective for Cardiac Implants by Application - Percentage Breakdown of Value Sales for Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application for the Years 2014, 2025 & 2030
  • TABLE 269: Iran Recent Past, Current & Future Analysis for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Iran Historic Review for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 271: Iran 16-Year Perspective for Cardiac Implants by End-user - Percentage Breakdown of Value Sales for Hospitals End-Users, Cardiology Centers End-Users and Other End-Users for the Years 2014, 2025 & 2030
• ISRAEL
  • TABLE 272: Israel Recent Past, Current & Future Analysis for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Israel Historic Review for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 274: Israel 16-Year Perspective for Cardiac Implants by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products for the Years 2014, 2025 & 2030
  • TABLE 275: Israel Recent Past, Current & Future Analysis for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Israel Historic Review for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 277: Israel 16-Year Perspective for Cardiac Implants by Application - Percentage Breakdown of Value Sales for Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application for the Years 2014, 2025 & 2030
  • TABLE 278: Israel Recent Past, Current & Future Analysis for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Israel Historic Review for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 280: Israel 16-Year Perspective for Cardiac Implants by End-user - Percentage Breakdown of Value Sales for Hospitals End-Users, Cardiology Centers End-Users and Other End-Users for the Years 2014, 2025 & 2030
• SAUDI ARABIA
  • TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Saudi Arabia Historic Review for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 283: Saudi Arabia 16-Year Perspective for Cardiac Implants by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products for the Years 2014, 2025 & 2030
  • TABLE 284: Saudi Arabia Recent Past, Current & Future Analysis for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Saudi Arabia Historic Review for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 286: Saudi Arabia 16-Year Perspective for Cardiac Implants by Application - Percentage Breakdown of Value Sales for Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application for the Years 2014, 2025 & 2030
  • TABLE 287: Saudi Arabia Recent Past, Current & Future Analysis for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Saudi Arabia Historic Review for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 289: Saudi Arabia 16-Year Perspective for Cardiac Implants by End-user - Percentage Breakdown of Value Sales for Hospitals End-Users, Cardiology Centers End-Users and Other End-Users for the Years 2014, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 290: UAE Recent Past, Current & Future Analysis for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 291: UAE Historic Review for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 292: UAE 16-Year Perspective for Cardiac Implants by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products for the Years 2014, 2025 & 2030
  • TABLE 293: UAE Recent Past, Current & Future Analysis for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 294: UAE Historic Review for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 295: UAE 16-Year Perspective for Cardiac Implants by Application - Percentage Breakdown of Value Sales for Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application for the Years 2014, 2025 & 2030
  • TABLE 296: UAE Recent Past, Current & Future Analysis for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 297: UAE Historic Review for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 298: UAE 16-Year Perspective for Cardiac Implants by End-user - Percentage Breakdown of Value Sales for Hospitals End-Users, Cardiology Centers End-Users and Other End-Users for the Years 2014, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Rest of Middle East Historic Review for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 301: Rest of Middle East 16-Year Perspective for Cardiac Implants by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products for the Years 2014, 2025 & 2030
  • TABLE 302: Rest of Middle East Recent Past, Current & Future Analysis for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Rest of Middle East Historic Review for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 304: Rest of Middle East 16-Year Perspective for Cardiac Implants by Application - Percentage Breakdown of Value Sales for Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application for the Years 2014, 2025 & 2030
  • TABLE 305: Rest of Middle East Recent Past, Current & Future Analysis for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Rest of Middle East Historic Review for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 307: Rest of Middle East 16-Year Perspective for Cardiac Implants by End-user - Percentage Breakdown of Value Sales for Hospitals End-Users, Cardiology Centers End-Users and Other End-Users for the Years 2014, 2025 & 2030
• AFRICA
  • Cardiac Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 308: Africa Recent Past, Current & Future Analysis for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Africa Historic Review for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 310: Africa 16-Year Perspective for Cardiac Implants by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products for the Years 2014, 2025 & 2030
  • TABLE 311: Africa Recent Past, Current & Future Analysis for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 312: Africa Historic Review for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 313: Africa 16-Year Perspective for Cardiac Implants by Application - Percentage Breakdown of Value Sales for Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application for the Years 2014, 2025 & 2030
  • TABLE 314: Africa Recent Past, Current & Future Analysis for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 315: Africa Historic Review for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 316: Africa 16-Year Perspective for Cardiac Implants by End-user - Percentage Breakdown of Value Sales for Hospitals End-Users, Cardiology Centers End-Users and Other End-Users for the Years 2014, 2025 & 2030

IV. COMPETITION